Healio3d
FDA accepts new drug application for SYD-101 to treat pediatric myopia progression
The FDA accepted a new drug application for SYD-101 to slow the progression of pediatric myopia and assigned a Prescription ...
FDA recall: 2 popular coffee creamers sold in Mississippi are making people sick. Did you buy?
International Delight coffee creamer sold in Mississippi now under FDA recall. Did you buy them? Are they in your home? What you need to know.
Ophthalmology Times3d
FDA accepts new drug application for low-dose atropine from Sydnexis
The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.
Business Insider24d
Chemomab completes End-of-Phase 2 Meeting with the FDA for CM-101
Nebokitug is the drug name recently assigned to CM-101 by the International Nonproprietary Names, or INN, program of the World Health Organization. The PSC pivotal trial design is focused on a set ...
Morningstar4d
Sydnexis Announces FDA Acceptance of New Drug Application for SYD-101 for the Treatment of Progression of Pediatric Myopia
FDA assigns a PDUFA target action date of October 23, 2025 If approved, SYD-101 would be the first and only pharmaceutical treatment option proven to slow the progression of pediatric myopia ...
MPR3d
Low-Dose Atropine Eye Drops Under Review for Pediatric Myopia
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of ...
Business Wire3d
Sydnexis Announces FDA Acceptance of New Drug Application for SYD-101 for the Treatment of Progression of Pediatric Myopia
If approved, SYD-101 would be the first and only pharmaceutical option for the treatment of progression of pediatric myopia in the United States. “The FDA acceptance of our NDA filing for SYD ...